![]() |
|
|
Vol. 290, Issue 3, 1132-1140, September 1999
Alcohol and Drug Abuse Research Center, Harvard Medical
School-McLean Hospital, Belmont, Massachusetts
Baseline nociception and opioid antinociception were compared in male
and ovariectomized female rhesus monkeys. Females were studied without
estradiol replacement or during treatment with estradiol
benzoate at doses (0.002 and 0.01 mg/kg/day) designed to mimic
17
-estradiol blood levels observed during different phases of the
menstrual cycle and during pregnancy. Baseline sensitivity to thermal
stimuli (42-54°C) was similar in male and ovariectomized female
monkeys. The antinociceptive effects of the µ-opioid agonists fentanyl, morphine, butorphanol, and nalbuphine were examined at 50 and
54°C. There were no sex-related differences in the antinociceptive effects of the high-efficacy µ agonist fentanyl; however, the lower-efficacy µ agonists morphine, butorphanol, and nalbuphine produced greater antinociceptive effects in males than in untreated ovariectomized females. Because butorphanol and nalbuphine have low
selectivity for µ versus
receptors and may produce
-agonist effects under some conditions, the high-efficacy,
-selective agonist
U50,488 was also studied. U50,488 also produced greater antinociceptive
effects in males. Treatment with estradiol benzoate tended to enhance
opioid antinociception in the ovariectomized females; however, this
effect was significant only for butorphanol and U50,488 during
treatment with the highest dose of estradiol benzoate. These findings
suggest that opioid agonists usually produce greater antinociception in
male monkeys than in females, and the magnitude of these sex-related
differences may be inversely related to efficacy at µ receptors or
selectivity for µ versus
receptors. Estradiol appears to have
little effect on µ-agonist antinociception in primates but may
enhance the antinociceptive effects of
agonists.
This article has been cited by other articles:
![]() |
X. Wang, R. J. Traub, and A. Z. Murphy Persistent pain model reveals sex difference in morphine potency Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R300 - R306. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Litschauer, G. Schaller, and M. Wolzt Naloxone does not influence cardiovascular responses to mild mental stress in postmenopausal women Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2120 - H2125. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Butelman, T. J. Harris, and M. J. Kreek Antiallodynic Effects of Loperamide and Fentanyl against Topical Capsaicin-Induced Allodynia in Unanesthetized Primates J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 155 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Evrard and J. Balthazart Rapid Regulation of Pain by Estrogens Synthesized in Spinal Dorsal Horn Neurons J. Neurosci., August 18, 2004; 24(33): 7225 - 7229. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. al'Absi, L. E. Wittmers, D. Ellestad, G. Nordehn, S. W. Kim, C. Kirschbaum, and J. E. Grant Sex Differences in Pain and Hypothalamic-Pituitary-Adrenocortical Responses to Opioid Blockade Psychosom Med, March 1, 2004; 66(2): 198 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Stevenson, J. E. Folk, D. C. Linsenmayer, K. C. Rice, and S. S. Negus Opioid Interactions in Rhesus Monkeys: Effects of {delta} + {micro} and {delta} + {kappa} Agonists on Schedule-Controlled Responding and Thermal Nociception J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1054 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Barrett, E. S. Smith, and M. J. Picker Capsaicin-Induced Hyperalgesia and {micro}-Opioid-Induced Antihyperalgesia in Male and Female Fischer 344 Rats J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 237 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. H. Ko, H. Lee, C. Harrison, M. J. Clark, H. F. Song, N. N. Naughton, J. H. Woods, and J. R. Traynor Studies of {micro}-, {kappa}-, and {delta}-Opioid Receptor Density and G Protein Activation in the Cortex and Thalamus of Monkeys J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 179 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Bowen, B. D. Fischer, N. K. Mello, and S. S. Negus Antagonism of the Antinociceptive and Discriminative Stimulus Effects of Heroin and Morphine by 3-Methoxynaltrexone and Naltrexone in Rhesus Monkeys J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 264 - 273. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-K. Zubieta, Y. R. Smith, J. A. Bueller, Y. Xu, M. R. Kilbourn, D. M. Jewett, C. R. Meyer, R. A. Koeppe, and C. S. Stohler {micro}-Opioid Receptor-Mediated Antinociceptive Responses Differ in Men and Women J. Neurosci., June 15, 2002; 22(12): 5100 - 5107. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Negus and N. K. Mello Effects of {micro}-Opioid Agonists on Cocaine- and Food-Maintained Responding and Cocaine Discrimination in Rhesus Monkeys: Role of {micro}-Agonist Efficacy J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1111 - 1121. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. D'Souza, R. E. Harlan, and M. M. Garcia Sexually dimorphic effects of morphine and MK-801: sex steroid-dependent and -independent mechanisms J Appl Physiol, February 1, 2002; 92(2): 493 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
Postmenopausal estrogen replacement therapy and increased rates of cholecystectomy and appendectomy Can. Med. Assoc. J., May 1, 2000; 162(10): 1421 - 1424. |
||||